At the annual meeting of the American Society of Clinical Oncology, the world’s largest cancer conference, the AI test will be unveiled.

Abiraterone has already helped hundreds of thousands with advanced prostate cancer to live longer, which is the most common form of the disease in men in more than 100 countries.